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counteracts Cyclosporin a side effects on
the ventral prostate
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Background: Cyclosporin A (CsA) is an immunosuppressive drug widely used in treatment of auto-immune
diseases or after organ transplants. However, several side effects are commonly associated with CsA long term
intake, some regarding to loss of reproductive organ function due to oxidative damage. Considering that
phytotherapy is an important tool often used against oxidative stress, we would like to describe the beneficial
effects of Heteropterys tomentosa intake to minimize the damage caused by CsA to the ventral prostate tissue of
Wistar rats under laboratorial conditions.
Methods: Thirty adult Wistar rats (Rattus norvegicus albinus) were divided into: control group (water); CsA group
(Cyclosporin A); Ht group (H. tomentosa infusion) and CsA + Ht group (CsA and H. tomentosa infusion). Plasmic
levels of hepatotoxicity markers, triglycerides, cholesterol and glucose were quantified. The ventral prostate tissue
was analyzed under light microscopy, using stereological, morphometrical and immunohistochemical techniques.
Results: H. tomentosa did not cause any alterations either of the plasmic parameters or of the ventral prostate
structure. CsA caused alterations of GOT, total and indirect bilirubin, cholesterol, triglycerides and glucose levels in
the plasma; CsA-treated rats showed alterations of the ventral prostate tissue. There were no alterations regarding
the plasma levels of GOT, triglycerides and glucose of CsA + Ht animals. The same group also showed normalization
of most of the parameters analyzed on the ventral prostate tissue when compared to the CsA group. The
treatments did not alter the pattern of AR expression or the apoptotic index of the ventral prostate epithelium.
Conclusions: The results suggest a protective action of the H. tomentosa infusion against the side effects of CsA on
the ventral prostate tissue, which could also be observed with plasmic biochemical parameters.
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Male reproductionBackground
Cyclosporin A (CsA), which is a neutral, hydrophobic
and cyclic peptide composed of 11 amino acid residues,
was originally obtained from the fungi Cylindrocapon
lucidum Booth and Tolypocladium inflatum Gams [1].
CsA is a powerful immunosuppressive drug that
improves survival rates and decreases the rejection epi-
sodes and hospitalization days of transplanted patients
[1,2]. CsA immunosuppressive properties are lymphocyte* Correspondence: karinemfreitas@gmail.com
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reproduction in any medium, provided the orspecific (cytotoxic and suppressor) and do not interfere
with phagocyte functions or haemopoietic stem cells [2,3].
CsA treatment causes many collateral effects, with
histopathological changes in various organs such as
thymus, kidney, liver, heart, pancreas, brain [4], testis
[5-10] and prostate [11]. The CsA-associated hepato-
toxicity could be demonstrated by alterations of plas-
mic levels of glutamic pyruvate transaminase (GPT),
glutamic oxalacetic transaminase (GOT), total proteins,
albumin, bilirubin (total, direct and indirect) and total
cholesterol [12-14]. In addition, the reduction of serum
testosterone levels caused by CsA is reported by many
authors [7,8,10].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CsA treatment reduced the ventral prostate weight, as well
as the volume of prostate components (epithelium, lumen,
muscular and non-muscular stroma), causing atrophy of
the prostate secretory epithelium. According to the
authors, these side effects would be associated both to the
reduction of serum testosterone levels caused by CsA and
to increased glycemia [11].
CsA use is fundamental in treatment of transplanted
patients, as well as for those affected by autoimmune
diseases. However, many side effects are related to its
use, thus, many studies aim to discover substances that
would decrease CsA side effects [6,12,15-19].
Heteropterys tomentosa A. Juss. (sin. Heteropterys aph-
rodisiaca O. Mach.) is a Brazilian native species; its roots
are used by the local population as a tonic or stimulant
in the treatment of the central nervous system debilities.
Some studies also showed the aphrodisiac characteristic
of this substance on male rodents [20-22]. A lyophilized
extract of H. tomentosa has proven to inhibit the inter-
action among biomolecules and free radicals in the brain.
Moreover, this treatment increased the amount of the anti-
oxidant enzymes: SOD (Superoxide Dismutase), MnSOD
(Manganese Superoxide Dismutase) and CuZnSOD
(Copper-Zinc Superoxide Dismutase) in old rat brains
[23], being efficient in the restoration of memory
damage in these animals [24].
H. tomentosa is also known by its hypoglycemiant prop-
erties and has been used against diabetes mellitus by trad-
itional communities in Mato Grosso state, Brazil [25,26].
Since H. tomentosa shows properties such as a strong
antioxidant capacity [23,24], a hypolgycemiant effect
[25,26] and an efficiency in reducing testicular damage
caused by CsA intake (in Wistar rats) [6], we were moti-
vated to analyze whether H. tomentosa infusion would
be efficient in reducing the damage caused by CsA to
the prostate tissue.
Methods
Medicinal plant and CsA
Heteropterys tomentosa roots were collected in Nova
Xavantina (Mato Grosso, Brazil) and indentified by
comparison with the voucher species of the plant in the
Federal University of Mato Grosso herbarium, Brazil
(registration number: 23928). The roots were dried at
room temperature, being protected against rain and direc-
ted incidence of sunlight. After desiccation, they were
crushed and powdered using a grinding mill. The infusion
was prepared by pouring 100 ml of boiling water on 25 g
of powdered roots. According to Marques et al. [27] water
is the best extracting liquid for H. tomentosa roots regard-
ing extractable solids. The final infusion had a yield of
6.832% (weight/weight) in terms of initial crude dry weight
of plant material, producing 68.66 mg of extract dry weightper ml of infusion [6]. The methodology used to prepare
the infusion and its dose were in accordance to that
showed in previous studies [6,28-30]
Cyclosporin A (Sandimmun Neoral – Oral Solution;
100 mg/ml; Novartis Pharma AG, Switzerland) was
diluted in distilled water or H. tomentosa infusion (dose
of 15.0 mg/kg/day). CsA dose was chosen according to
previous studies [6,11,31].
Experimental animals and treatment protocol
Rattus norvervegicus albinus, Wistar rats, (24 animals,
mean weight 405.66 g ± 29.76 g, 90 days-old) were ran-
domly divided into 4 experimental groups (n = 6 in each
group). The control group received distilled water;
CsA group received Cyclosporin A; Ht group received
H. tomentosa infusion; CsA + Ht group received CsA and
H. tomentosa simultaneously. All treatments described
above were administered daily by gavage (0.5 ml) during
56 days. CsA and H. tomentosa mixture was prepared di-
luting the dose of CsA in 0.5 ml of the plant infusion.
The animals were obtained from the Center for Biological
Investigation - CEMIB (State University of Campinas,
Campinas, SP, Brazil), and housed three per cage, under
standard conditions with 12 hr. light/dark cycle.
Animals were weighted and anesthetized (between 9
to 11 o’clock in the morning) with xylazine and ketamine
injection in the quadriceps femoris muscle (5 and
80 mg/kg body weight, respectively). The abdomen and
thoracic cavities were opened. Testis, epididymis, sem-
inal vesicle, coagulating gland, ventral prostate, kidney
and liver were excised and weighed. The experimental
protocol (#2295-1) was approved by the Institutional
Committee for Animal Care and Use of the State Uni-
versity of Campinas.
Blood samples and biochemical assays
Blood samples were taken from the left ventricle by car-
diac puncture and stored in VacuetteW tubes (Sodium
Heparin) under refrigeration (4ºC). They were centri-
fuged at 1,400x G, for 10 minutes (4ºC).
Blood samples were sent to specialized laboratories in
order to quantify the amount of glutamic pyruvate trans-
aminase (GPT), glutamic oxalacetic transaminase (GOT),
total proteins, bilirubin (total, direct and indirect), trigly-
cerides and cholesterol (all by enzymatic method); and
albumin (by colorimetric method) (Laboratório Álvaro,
Cascavel, Brazil), as well as glucose (by kinetic method)
(Laboratório VetPat, Campinas, Brazil). These were
quantified in order to detect possible toxic effect due to
the plant infusion and/or CsA intake.
Light microscopy
Following dissection, the ventral prostate lobes were
separated; one of them was immersed in Karnovsky’s
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0.1 M phosphate buffer, pH 7.2) for 24 h at room
temperature. After fixation, the tissue was routinely em-
bedded in hydroxyethyl methacrylate (HistoresinW,
Leica). Two micrometer sections were obtained, stained
with hematoxylin-eosin and observed with an Olympus
BX-40 light microscope.
The contralateral lobe was immersed in Methacarn
(Methanol: chloroform: acetic acid – 6:3:1) during 4 hours
and paraffin embedded. Thus, 5 μm sections were made
for AR immunohistochemistry and TUNEL assay.
Morphometry and stereology
All morphometrical and stereological evaluations were
made using the resin embedded material. The Image Pro
Plus software was used for morphometrical and stereologi-
cal analyses. The volumetric densities of lumen, epithelium,
muscular and non-muscular stroma were determined
using a 130-point grid system in ten randomly chosen
microscopic fields. Absolute volumes were estimated
multiplying the volumetric density by the prostate weight
[32] since the ventral prostate density could be considered
as approximately 1.0 [33]. The epithelial and muscular
stroma thicknesses (μm) were measured. Nuclear area
(μm2), perimeter (μm) and cytoplasm area (μm2) were
measured and the form factor (4π X nuclear area / [nuclear
perimeter]2) was calculated. For standardization, all quanti-
fications were made of the intermediary region of the ven-
tral prostate.
AR immunohistochemistry
Paraffin was removed from sections prior to hydration.
Antigenic retrieval was made by section immersion in
citrate buffer, kept at high temperature (100°C) for
45 minutes. Hydrogen peroxide (3%) in methanol (dur-
ing 20 minutes) was used to block endogenous peroxid-
ase. The slides were incubated with the primary
antibody anti-AR (Androgen receptor; SC-816, Santa
Cruz Biotechnology, USA), at 37°C, for 1 hour and in-
cubated with biotinylated secondary antibody at 37°C
for 45 minutes. The slides were then incubated with
peroxidase-conjugated avidin–biotin complexes. The po-
sitive reaction was revealed by diaminobenzidine. The
sections were counterstained with Harris’s hematoxylin
for 10 seconds.
Terminal transferase d UTP Nick End Labeling (TUNEL)
technique
A kit for fragmented DNA detection (US1QIA33-1EA;
TdT FragEL TM DNA Fragment. Detect, Merck) was used
for apoptotic nuclei detection. The slides were incubated
with Proteinase K for permeabilization followed by en-
dogenous peroxidase activity blocking with 3% hydrogen
peroxide in methanol for 5 min. Equilibrium reaction,labeling, detection and revelation with diaminobenzidine
were made according to the kit manufacturer’s instructions.
The slides were counterstained with Harris’ hematoxylin
for 8 sec.
The apoptotic index was calculated by counting la-
beled nuclei within the epithelium of 10 different fields
(40x objective) for each animal, dividing the result by
the total number of epithelial cells within the fields [34].
Statistical analysis
Normality test was done for all the parameters, using
the software Minitab 16. If the parameter values had
normal distribution, the averages were compared by
variance analysis (ANOVA) and with post hoc Duncan’s
test, using the software Statistica 8. If not, the nonpara-
metric test (Kruskal Wallis Multiple Comparison) was
performed. For all the tests the significance was 95%. All
data are presented as mean ± standard deviation (SD).
Results
Plasmic biochemistry assays
Plasmic levels of GPT, total proteins and albumin did
not vary among experimental groups (Table 1).
GOT plasmic level was increased in the CsA group when
compared to the control (p = 0.041). That parameter was
normal for CsA +Ht group. Total bilirubin was signifi-
cantly higher for the groups treated with CsA (CsA and
CsA +Ht) when compared to the control (p = 0.0004 and
0.001, respectively). The dosage of indirect bilirubin
showed a significant increase in the CsA and CsA +Ht
groups (p = 0.003 and 0.045, respectively) (Table 1).
Triglycerides, cholesterol and glucose levels were sig-
nificantly higher in the CsA group, when compared to
the control (p = 0.006, 0.049 and 0.001, respectively)
(Table 1). The increase of triglycerides and glucose levels
caused by CsA treatment were not observed in the CsA +
Ht group; however the increase of cholesterol levels was
observed (p = 0.005).
The treatment with H. tomentosa infusion (Ht group)
did not cause any alteration of the plasmic parameters
analyzed.
Biometrical parameters
The treatment with CsA did not significantly alter the
final body weight or body weight gain in CsA and CsA +
Ht group (Figure 1). However the final body weight and
body weight gain were lower in CsA group when com-
pared to CsA+Ht group (p = 0.029 and 0.027, respectively)
(Figure 1).
CsA treatment caused reduction of the ventral prostate
(p = 0.006), coagulating gland (p = 0.002) and epididymis
(p = 0.022) weights and increased kidney (p = 0.009) and
liver (p = 0.016) weights in the CsA group when compared
to the control (Table 2). CsA +Ht group did not show any
Table 1 Plasma biochemical dosages of Wistar rats treated with CsA, H. tomentosa infusion or both treatments
simultaneously
Parameters Experimental Groups
Control CsA Ht CsA + Ht
GOT (U/L) 125.0 ± 33.05a 188.8 ± 39.8b 132.9 ± 53.32ab 127.6 ± 39.90a
#GPT (U/L) 48.90 ± 8.59 73.36 ± 45.21 47.48 ± 10.14 58.42 ± 16.68
#Total Proteins (g/dL) 6.14 ± 0,089 6.08 ± 0.19 6.2 ± 0.141 6.12 ± 0.55
Albumin (g/dL) 3.64 ± 0.11 3.46 ± 0.18 3.58 ± 0.26 3.38 ± 0.15
Total Bilirubin (mg/dL) 0.15 ± 0.04a 0.24 ± 0.01b 0.14 ± 0.031a 0.23 ± 0.04b
Direct Bilirubin (mg/dL) 0.07 ± 0.04 0.05 ± 0.05 0.07 ± 0.03 0.08 ± 0.06
Indirect Bilirubin (mg/dL) 0.08 ± 0.03a 0.20 ± 0.05b 0.07 ± 0.02a 0.15 ± 0.08b
#Triglycerides (mg/dL) 107.7 ± 44.74a 292.1 ± 74.10b 122.6 ± 78.07a 177.5 ± 94.88ab
Cholesterol (mg/dL) 62.74 ± 2.09a 73.16 ± 11.19b 59.48 ± 8.04a 79.18 ± 6.82b
#Glucose (mg/dL) 272.8 ± 27.58a 408.9 ± 65.17b 281.7 ± 44.83a 266.2 ± 48.45a
Control: control group; CsA: Cyclosporin A treated group; Ht: Heteropterys tomentosa infusion treated group; and CsA + Ht: group with simultaneously treatment
with CsA and H. tomentosa.
The values are mean ± SD. In each row, values with different superscripts are significantly different (p < 0.05). The parameters preceded by # did not show normal
distribution, and therefore were compared using a nonparametric test. The others were compared with ANOVA post hoc with Duncan’s test.
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liver weights when compared to the control animals, al-
though the coagulating gland weight was lower in this
same group (p = 0.010) (Table 2).
Stereology and morphometry
The volumetric proportions of ventral prostate tissue
components (lumen, epithelium, muscular and non-
muscular stroma) did not vary among the experimental
groups (Data not shown).
CsA-treatment caused significant reduction of the vol-
ume of all ventral prostate tissue components - lumen,
epithelium, muscular and non-muscular stroma - in theFigure 1 Body weight and body weight gain (both in grams) of
Wistar rats treated with water (Control), Cyclosporin A (CsA),
Heteropterys tomentosa infusion (Ht), CsA and H. tomentosa
infusion simultaneously (CsA + Ht). The values are mean ± SD. In
each column, values with different letters are significantly different
(p < 0.05), according to Duncan’s test.CsA group when compared to the control (p = 0.027,
0.022, 0.019 and 0.004, respectively) (Figure 2). How-
ever, when CsA was administered simultaneously with
H. tomentosa, this reduction did not occur (Figure 2).
The proportion of nuclei and cytoplasm of the ven-
tral prostate epithelial cells in the CsA group was
higher or lower, respectively, when compared to the
values of CsA +Ht group (p = 0.007 for both) (Figure 3).
The total (p = 0.002), nuclear (p = 0.015) and cytoplasmatic
(p = 0.002) area of ventral prostate epithelial cells was
smaller in the CsA treated group when compared to the
control (Figure 4). Similar result was not observed when
the plant infusion was administered along with CsA
(Figure 4).
The CsA group also showed reduced epithelium and
muscular stroma thickness when compared to the con-
trol (p = 0.022 and 0.014, respectively). This result was
not observed for the CsA +Ht group (Figure 4).
AR immunohistochemistry and TUNEL
Most nuclei of all experimental groups were AR posi-
tively labeled (Figure 5). Some stromal cells also showed
the same positive reaction (Figure 5). There were no dif-
ferences in the pattern of AR expression among the ex-
perimental groups (Figure 5).
The apoptotic index did not vary after the treatments,
being lower that 0.5% in all of them.
Discussion
The CsA dose and the administration route employed
in the present study were in accordance with the man-
ufacturer’s recommendations for patients after organ
transplantation and the same used in previous studies
[6,16,18,35]. The method of H. tomentosa infusion
Table 2 Absolute (g) and relative (%) organs’ weight of Wistar rats treated with CsA, H. tomentosa infusion or both
simultaneously
Parameters Experimental Groups
Control CsA Ht CsA + Ht
Weight (g)
Ventral Prostate 0.499 ± 0.13a 0.332 ± 0.04b 0.481 ± 0.08a 0.398 ± 0.11ab
#Seminal Vesicle 0.97 ± 0.10 0.79 ± 0.27 0.93 ± 0.27 0.82 ± 0.17
Coagulating Gland 0.21 ± 0.03a 0.15 ± 0.02b 0.21 ± 0.04a 0.16 ± 0.03b
Testis 1.96 ± 0.11 1.88 ± 0.23 1.97 ± 0.14 1.87 ± 0.19
Epididymis 0.61 ± 0.02ac 0.55 ± 0.53b 0.64 ± 0.03c 0.58 ± 0.05ab
Kidney 1.49 ± 0.16ac 1.74 ± 0.17b 1.52 ± 0.13c 1.69 ± 0.17bc
Liver 15.92 ± 2.23a 19.25 ± 1.91b 15.49 ± 2.64a 16.80 ± 2.62ab
Control: control group; CsA: Cyclosporin A treated group; Ht: Heteropterys tomentosa infusion treated group; and CsA + Ht: group with simultaneously treatment
with CsA and H. tomentosa.
The values are mean ± SD. In each row, values with different superscripts are significantly different (p < 0.05). The parameters preceded by # did not show normal
distribution, therefore were compared using a nonparametric test. The others were compared with ANOVA post hoc with Duncan’s test.
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on methods applied in previous studies [6,28-30].
CsA administration is fundamental to avoid tissue
rejection after organ transplantation and against auto-
immune diseases, although several important side
effects are reported. Thus, many studies seek a sub-
stance that would be able to diminish CsA side effects
[6,12,16-19,35,36]. Many substances were efficient to
protect the renal tissue of Wistar rats from CsA
induced nephropathy, among them, Vitamin E [15],
L-propionylcarnitine [36], carvedilol [16], green tea extract
[17] and shallot (Allium ascalonicum L.) extract [19]. Fur-
thermore, Kurus et al. [12] observed that oral administra-
tion of L-arginine prevented liver damage caused by CsA
administration. Regarding the protection against CsAFigure 2 Volume (mL) of ventral prostate tissue components
(lumen, epithelium, muscular and non-muscular stroma) of
Wistar rats treated with water (Control), Cyclosporin A (CsA),
Heteropterys tomentosa infusion (Ht), CsA and H. tomentosa
infusion simultaneously (CsA + Ht). The values are mean ± SD. In
each column, values with different letters are significantly different
(p < 0.05), according to Duncan’s test.testicular impairment, Türk et al. [18] observed that
lycopene had a potential protective effect against the
CsA-induced oxidative stress leading to structural and
functional damages in the testicular tissue and sperm
quality of rats. Finally, Monteiro et al. [6] observed that
H. tomentosa infusion was efficient to protect the tes-
ticular parenchyma, specially the seminiferous epithe-
lium, against structural damage caused by CsA.
Heteropterys tomentosa infusion did not cause alter-
ation of GOT, GPT, bilirubin (total, direct and indirect),
total proteins, albumin, urea, cholesterol, triglycerides or
glucose plasmatic levels, indicating that the plant infu-
sion had no toxic effect.
In the present study, CsA did not cause alterations of the
GPT levels, total proteins and albumin; but significantlyFigure 3 Proportion between nucleus and cytoplasm of a
ventral prostate epithelial cell from Wistar rats treated with
water (Control), Cyclosporin A (CsA), Heteropterys tomentosa
infusion (Ht), CsA and H. tomentosa infusion simultaneously
(CsA + Ht). The values are mean ± SD. In each column, values with
different letters are significantly different (p < 0.05), according to
Duncan’s test.
Figure 4 Nuclei, cytoplasm and total epithelial cell areas;
epithelium and muscular stroma thickness of the ventral
prostate of Wistar rats treated with water (Control),
Cyclosporin A (CsA), Heteropterys tomentosa infusion (Ht), CsA
and H. tomentosa infusion simultaneously (CsA + Ht). The values
are mean ± SD. In each column, values with different letters are
significantly different (p < 0.05), according to Duncan’s test, except
for Epithelium thickness (#) - Kruskal Wallis Multiple Comparison test.
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[12,13], CsA-induced hepatotoxicity can be detected either
by elevated serum GOT and GPT levels and/or reduced
total protein content. Kurus et al. [12] working with ani-
mals treated with 7.5 mg/kg/day of CsA injected subcuta-
neously during 28 days observed increased levels of GOT
and GPT. On the other hand, in the study carried out by
Bohmer et al. [31] using CsA (5 and 15 mg/kg/day) admi-
nistered by gavage during 8 weeks, the authors did not ob-
serve alterations of GOT and GPT levels. These authors
had the same experimental protocol of that used in the
present study, the differences in the results are probably
due to individual differences of the experimental animals
in relation to the treatment. Thus, we believe that the
elevation of GOT level observed in the present study
can be related to CsA hepatotoxicity; the group treated
with H. tomentosa infusion along with CsA did not
show altered GOT levels indicating attenuation of CsA-
associated hepatotoxicity.
Increased total serum bilirubin is usually associated
with CsA-induced hepatotoxicity [12,14]. In the present
study, the increase of total plasma bilirubin observed in
CsA and CsA +Ht groups was due to the increase of in-
direct bilirubin, since there was no alteration of direct
bilirubin levels; this result could indicate that CsA
affects the conversion of unconjugated bilirubin (indir-
ect) to conjugated bilirubin (direct), probably due to
hepatic damage.
The CsA-induced hepatotoxicity is probably related to
the increase of reactive species of oxygen as confirmed
by previous studies [12,37]. According to Rezzani et. al.
[37] the responsive mechanism for oxidative stress asso-
ciated with CsA administration is due to the imbalancebetween free oxygen radical production and the liver’s
antioxidant defense system. CsA-induced oxidative stress
is positively correlated with biochemical parameters
characteristic of hepatotoxicity [13].
CsA treatment increased total cholesterol of both
groups treated with the drug; this result was similar to
that observed by Vaziri et al. [38]. Triglycerides and glu-
cose levels were higher in the CsA group. Such higher
levels were not observed in the animals that received the
plant infusion along with CsA. Previous studies showed
that hyperglycemia is associated with CsA-treatment
[11,39]. H. tomentosa is popularly known as a hipogly-
cemiant medicinal plant [25]; the maintenance of nor-
mal glucose levels in the CsA +Ht group could be
related to the hipoglycemiant property of H. tomentosa.
The animals treated only with H. tomentosa showed no
alteration of glucose levels. Therefore, H. tomentosa
could be efficient as a hipoglycemiant only in animals
with hyperglycemia.
The body weight was assessed to determine the effects
of the CsA treatment on the general health of the ani-
mals [40]. Monteiro et al. [6] did not observe any signifi-
cant difference of body weight gain of animals treated
with CsA or CsA along with H. tomentosa, as was also
observed in the present study. However, the final body
weight and body weight gain increased in the group
treated simultaneously with CsA and H. tomentosa,
when compared to that treated only with CsA.
The ventral prostate and coagulating gland are andro-
gen responsive glands and their weight variations could
be related to testosterone level alterations [41,42]. The
reduction of those glands weights could be related to
testosterone level reduction caused by CsA. The CsA +
Ht group also showed reduction of the coagulating
gland, when compared to the control but the ventral
prostate weight did not vary. Monteiro et al. [6] work-
ing with the same dose/treatment period of CsA and
H. tomentosa did not observe alterations of ventral
prostate and coagulating gland weights, contrary to that
observed in the present study. Possibly this could be due
to individual differences in the animals’ response and
sensitivity to the treatment. Türk et al. [18] observed
lower seminal vesicle weights in rats treated with CsA
(dose of 15 mg/kg by subcutaneous injection, during
21 days) and unaltered seminal vesicle weights in rats
treated with CsA + lycopene. These authors did not ob-
serve variation of testis, epididymis and prostate weights.
The difference between the present research and the
findings of Türk et al. [18] could be due to the difference
in the CsA administration route and treatment duration.
CsA caused extensive damage in the ventral prostate
tissue and atrophy of some epithelial regions [11]. Ultra-
structural analyses showed that there was less rough
endoplasmic reticulum and Golgi complex in atrophied
Figure 5 AR immunohistochemistry in the ventral prostate sections. Groups: Control (A and B), CsA-treated (C and D), H. tomentosa
infusion treated (E and F) and treated simultaneously with CsA and infusion (G and H). Legend: arrowheads = atrophied epithelium;
s = stroma; asterisks = lumen; e = epithelium. Bars = 50 μm (A, C, E and G) and Bars = 10 μm (B, D, F and H).
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secretory activity. The damage caused by CsA to the
prostate tissue was probably related to the lower serum
testosterone levels and higher glucose levels [11].
The morphometrical and stereological analyses showed
that simultaneous CsA and H. tomentosa administrationprotected the prostate tissue against the impairment
caused by CsA administration. The alterations observed
in the volume of prostate tissue components (lumen,
epithelium, muscular and non muscular stroma) in the
CsA group, were not observed in the CsA +Ht group.
The ventral prostate epithelium and muscular stroma
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thelial cell (area of nucleus + cytoplasm) were signifi-
cantly higher in the CsA + Ht group, when compared to
the CsA group. These results showed that the effects of
CsA on ventral prostate tissue were reduced in the ani-
mals treated with H. tomentosa and CsA.
In the previous report of Shabisgh et al. [34], there
was virtually no apoptosis in the ventral prostate of con-
trol Wistar rats. The apoptotic index of all the groups in
the present study was less that 0.5, which is considered
normal for the ventral prostate epithelium of non treated
animals [34]. Freitas et al. [11] suggested that the un-
altered apoptotic index in animals treated with CsA for
56 days was due to the long term treatment. In castrated
animals the apoptotic index reaches its peak at 72 hours
after surgery. After this period, it starts declining, be-
coming normal after 7 days [34,43]. Therefore, the apop-
totic index was not a good parameter to observe
possible benefits of H. tomentosa treatment associated
with CsA administration over 56 days.
Androgen receptors are present in most epithelial and
smooth muscle cells (periductal and perivascular) and in
some fibroblast cells of the rat ventral prostate [30]. AR
expression in all experimental groups was similar to that
cited above. Since the reaction intensity of AR-positive
cells could be related to an increase in AR expression
[44], the absence of any variation suggests that no alter-
ation of AR expression occurred.
Mattei et al. [23] observed that the treatment with
H. tomentosa extract increased the total activities of
SOD, MnSOD and CuZnSOD in old rats’ brains. Thus,
the protection provided by H. tomentosa against the
prostatic damage induced by CsA intake would be related
to antioxidant properties of H. tomentosa. In addition,
considering that CsA causes hyperglycemia, leading to
epithelial atrophy in the ventral prostate, the hypoglice-
miant properties of H. tomentosa would be directly
related to the reduction of CsA-associated side effects.
Conclusions
This study did not show any toxicity related to Heterop-
terys tomentosa infusion administration based on the
plasma content. Furthermore it indicated possible pro-
tection of H. tomentosa infusion on the prostate tissue
against the damage caused by CsA. The alteration of
hepatotoxic plasmic biochemical parameters also showed
that the CsA-induced hepatotoxicity was reduced in the
animals treated simultaneously with the plant infusion.
New investigations are necessary to evaluate whether the
plant infusion would interfere with the CsA immunosup-
pressant activity.
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